Literature DB >> 26024071

Regional assessment of energy-producing metabolic activity in the endothelium of donor corneas.

Mark A Greiner1, Kimberlee A Burckart2, Michael D Wagoner3, Gregory A Schmidt2, Cynthia R Reed2, Chase A Liaboe3, Miles J Flamme-Wiese3, M Bridget Zimmerman4, Robert F Mullins3, Randy H Kardon5, Kenneth M Goins1, Benjamin T Aldrich1.   

Abstract

PURPOSE: We characterized mitochondrial respiration and glycolysis activity of human corneal endothelium, and compared metabolic activity between central and peripheral regions.
METHODS: Endothelial keratoplasty-suitable corneas were obtained from donors aged 50 to 75 years. The endothelium-Descemet membrane complex (EDM) was isolated, and 3-mm punches were obtained from central and peripheral regions. Endothelium-Descemet membrane punches were assayed for mitochondrial respiration (oxygen consumption) and glycolysis (extracellular acidification) using an extracellular flux analyzer. Enzymatic (citrate synthase, glucose hexokinase) and mitochondrial density (MitoTracker) assays also were performed.
RESULTS: Ten corneas were analyzed per assay. Metabolic activity for mitochondrial respiration and glycolysis showed expected changes to assay compounds (P < 0.01, all pairwise comparisons). Basal mitochondrial respiration and glycolysis activity did not differ between regions (P > 0.99). Similarly, central versus peripheral activity after assay compound treatment showed no significant differences (P > 0.99, all time points). The intracorneal coefficient of variation for basal readings between two and four peripheral punches was 18.5% of the mean. Although peripheral samples displayed greater enzymatic activity than central samples (P < 0.05), similar to extracellular flux results, mitochondrial density did not differ between regions (P = 0.78).
CONCLUSIONS: Extracellular flux analysis of oxygen and pH is a valid technique for characterizing metabolic activity of human corneal endothelium. This technique demonstrates high reproducibility, allows quantification of metabolic parameters using small quantities of live cells, and permits estimation of overall metabolic output. Neither oxygen consumption nor extracellular acidification differed between central and peripheral regions of transplant suitable corneas in this series. Our results show that endothelial cell health can be quantified biochemically in transplant suitable corneas.

Entities:  

Mesh:

Year:  2015        PMID: 26024071     DOI: 10.1167/iovs.15-16442

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  5 in total

1.  Investigating the Effects of Coenzyme Q10 on Human Corneal Endothelial Cells.

Authors:  Mitchell Titley; Sajjad Ahmad; Mohit Parekh
Journal:  J Ophthalmol       Date:  2021-08-12       Impact factor: 1.909

2.  Mitochondrial oxygen metabolism in primary human lens epithelial cells: Association with age, diabetes and glaucoma.

Authors:  M Kubota; Y B Shui; M Liu; F Bai; A J Huang; N Ma; D C Beebe; C J Siegfried
Journal:  Free Radic Biol Med       Date:  2016-07-19       Impact factor: 7.376

3.  Feeder-free differentiation of cells exhibiting characteristics of corneal endothelium from human induced pluripotent stem cells.

Authors:  Michael D Wagoner; Laura R Bohrer; Benjamin T Aldrich; Mark A Greiner; Robert F Mullins; Kristan S Worthington; Budd A Tucker; Luke A Wiley
Journal:  Biol Open       Date:  2018-05-08       Impact factor: 2.422

4.  Mitochondria as a Platform for Dictating the Cell Fate of Cultured Human Corneal Endothelial Cells.

Authors:  Kohsaku Numa; Morio Ueno; Tomoko Fujita; Koji Ueda; Nao Hiramoto; Atushi Mukai; Yuichi Tokuda; Masakazu Nakano; Chie Sotozono; Shigeru Kinoshita; Junji Hamuro
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-12-01       Impact factor: 4.799

5.  Metabolites Interrogation in Cell Fate Decision of Cultured Human Corneal Endothelial Cells.

Authors:  Junji Hamuro; Kohsaku Numa; Tomoko Fujita; Munetoyo Toda; Koji Ueda; Yuichi Tokuda; Atushi Mukai; Masakazu Nakano; Morio Ueno; Shigeru Kinoshita; Chie Sotozono
Journal:  Invest Ophthalmol Vis Sci       Date:  2020-02-07       Impact factor: 4.799

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.